Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $12.1500 (3.67%) ($12.0750 - $12.1500) on Fri. Sep. 29, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.65% (three month average) | RSI | 38 | Latest Price | $12.1500(3.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD declines -0.2% a day on average for past five trading days. | Weekly Trend | FOLD declines -3.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(70%) IBB(65%) ARKG(60%) CEMB(48%) IWO(47%) | Factors Impacting FOLD price | FOLD will decline at least -1.325% in a week (0% probabilities). TBT(-35%) UUP(-17%) VXX(-11%) URA(-2%) DRIV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.325% (StdDev 2.65%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $5.44(-55.23%) | Resistance Level | $12.6 | 5 Day Moving Average | $12.18(-0.25%) | 10 Day Moving Average | $12.33(-1.46%) | 20 Day Moving Average | $12.6(-3.57%) | To recent high | -11.9% | To recent low | 3.7% | Market Cap | $3.137b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |